We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$43.8B
AUM Growth
+$1B
Cap. Flow
-$59.5M
Cap. Flow %
-0.14%
Top 10 Hldgs %
14.97%
Holding
3,057
New
207
Increased
1,365
Reduced
1,344
Closed
128

Sector Composition

Rank Sector Weight
1 Financials 16.4%
2 Technology 15.29%
3 Healthcare 13.69%
4 Industrials 10.84%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GORO icon
2651
Goldgroup Mining Inc.
GORO
$155M
$248K ﹤0.01%
60,797
+13,165
+28% +$50.1K
ARA
2652
DELISTED
American Renal Associates Holdings, Inc
ARA
$248K ﹤0.01%
13,383
+354
+3% +$6.15K
VATE icon
2653
INNOVATE Corp
VATE
$106M
$247K ﹤0.01%
4,204
+894
+27% +$51.3K
FBMS
2654
DELISTED
The First Bancshares, Inc.
FBMS
$246K ﹤0.01%
+8,902
New +$250K
WEYS icon
2655
Weyco Group
WEYS
$377M
$245K ﹤0.01%
8,798
-1,301
-13% -$36.1K
MXWL
2656
DELISTED
Maxwell Technologies Inc
MXWL
$245K ﹤0.01%
40,863
+8,781
+27% +$51.1K
VIA
2657
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$243K ﹤0.01%
+2,586
New +$250K
MYOK
2658
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$242K ﹤0.01%
18,489
+5,773
+45% +$76.1K
RT
2659
DELISTED
Ruby Tuesday Georgia
RT
$242K ﹤0.01%
120,302
-2,771
-2% -$6.58K
CRIS icon
2660
Curis
CRIS
$9.71M
$241K ﹤0.01%
64
+1
+2% +$4.18K
CVLG icon
2661
Covenant Logistics
CVLG
$1.04B
$241K ﹤0.01%
27,490
+1,520
+6% +$13.7K
GDEN
2662
DELISTED
Golden Entertainment
GDEN
$241K ﹤0.01%
11,650
+605
+5% +$9.98K
IPI icon
2663
Intrepid Potash
IPI
$476M
$241K ﹤0.01%
+10,644
New +$223K
RARX
2664
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$241K ﹤0.01%
+12,834
New +$290K
STS
2665
DELISTED
Supreme Industries Inc Class A
STS
$241K ﹤0.01%
14,657
+840
+6% +$15.5K
AC
2666
DELISTED
Associated Capital Group
AC
$240K ﹤0.01%
7,102
-373
-5% -$12.6K
NERV icon
2667
Minerva Neurosciences
NERV
$191M
$240K ﹤0.01%
3,385
+893
+36% +$57.8K
CHMI
2668
Cherry Hill Mortgage Investment Corp
CHMI
$82.3M
$239K ﹤0.01%
+12,955
New +$232K
RNAC icon
2669
Cartesian Therapeutics
RNAC
$218M
$239K ﹤0.01%
+402
New +$178K
FNHC
2670
DELISTED
FedNat Holding Company Common Stock
FNHC
$239K ﹤0.01%
14,952
-160
-1% -$2.55K
ICHR icon
2671
Ichor Holdings
ICHR
$2.17B
$238K ﹤0.01%
+11,827
New +$251K
EGIO
2672
DELISTED
Edgio, Inc. Common Stock
EGIO
$238K ﹤0.01%
2,061
-38
-2% -$4.41K
CNBKA
2673
DELISTED
Century Bancorp Inc/Mass
CNBKA
$238K ﹤0.01%
3,745
-665
-15% -$41.6K
ASCMA
2674
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$238K ﹤0.01%
15,471
-815
-5% -$11.3K
LCTX icon
2675
Lineage Cell Therapeutics
LCTX
$264M
$237K ﹤0.01%
85,955
+16,237
+23% +$45.4K

Similar funds

RhumbLine Advisers's Q2 2017 Portfolio in Review

As of Q2 2017, RhumbLine Advisers held 3,057 positions worth $43.8B, up 2.3% from $42.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers's Q2 2017 filing shows 207 new, 1,365 increased, 1,344 reduced and 128 closed positions. Its largest new stake was DXC Technology: 615,360 shares worth $40.8M. The largest sale was Yahoo Inc, an estimated $68.4M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q2 2017 buy was DXC Technology: 615,360 shares worth $40.8M.
  • RhumbLine Advisers added most to IHS Markit Ltd. Common Shares in Q2 2017, an estimated $26.7M increase.
  • RhumbLine Advisers's biggest Q2 2017 reduction was Apple, cutting an estimated $23.6M.
  • RhumbLine Advisers fully exited Yahoo Inc in Q2 2017, selling an estimated $68.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $43.8B portfolio in Q2 2017.
  • RhumbLine Advisers opened 207 new positions and closed 128 in Q2 2017.
  • RhumbLine Advisers's portfolio value rose 2.3% quarter-over-quarter to $43.8B.

Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.